Professor | Qizhu Tang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Qizhu Tang
Contact Information	qztang@whu.edu.cn
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Qizhu Tang

Contact Information

qztang@whu.edu.cn

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1981.9-1986.6 Bachelor of Medicine: Hubei Medical College 1988.9-1991.6 Master of Cardiovascular Diseases: Hubei Medical College 2000.9-2003.6 PhD in Cardiovascular Diseases: Wuhan University 2004.9-2007.6 EMBA: Peking University China Center for Economic Research Published over 300 papers, including 120 SCI papers Edited 7 monographs, participated in 22 2 first prizes of Hubei Province Science and Technology Progress Award 2 invention patents, 1 utility model patent, 1 software copyright
Work Experience	1986.7-1988.8 Physician, Hubei Medical University First Hospital 1991.7-1993.10 Physician in Cardiology, Hubei Medical University First Hospital 1993.10-1995.9 Attending Physician in Cardiology, Hubei Medical University First Hospital 1995.10-1999.3 Associate Chief Physician and Associate Professor in Cardiology, Hubei Medical University First Hospital 1999.3-2000.8 Chief Physician and Associate Professor in Cardiology, Hubei Medical University First Hospital 2000.8-2001.1 Chief Physician and Associate Professor in Cardiology, Renmin Hospital of Wuhan University 2001.1-present Chief Physician and Professor in Cardiology, Renmin Hospital of Wuhan University 1997.8-2000.8 Standing Committee Member and Vice President, Hubei Medical University First Hospital 2000.8-2005.4 Standing Committee Member and Vice President, Renmin Hospital of Wuhan University 2005.4-2014.6 Party Secretary and Vice President, Renmin Hospital of Wuhan University 2014.6-2016.9 President and Party Secretary, Renmin Hospital of Wuhan University 2016.9-2019.11 President, Renmin Hospital of Wuhan University 2019.1-present Standing Committee Member, Vice President and Medicine Minister, Wuhan University
Awards	2013: First Prize of Hubei Province Science and Technology Progress Award (Myocardial remodeling and clinical prevention) 2019: First Prize of Hubei Province Science and Technology Progress Award (Structural remodeling and prevention of heart failure) 2001: Second Prize of National Science and Technology Progress Award (Atrioventricular reentrant tachycardia and radiofrequency ablation) 2011: Second Prize of National Science and Technology Progress Award (Structural and neural remodeling in arrhythmias and clinical prevention) 2005: Second Prize of National Science and Technology Progress Award (Basic and clinical research on atrial fibrillation) 2016: First Prize of Hubei Province Science and Technology Progress Award (Construction and application of cardiovascular disease model animals)

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1981.9-1986.6 Bachelor of Medicine: Hubei Medical College
1988.9-1991.6 Master of Cardiovascular Diseases: Hubei Medical College
2000.9-2003.6 PhD in Cardiovascular Diseases: Wuhan University
2004.9-2007.6 EMBA: Peking University China Center for Economic Research
Published over 300 papers, including 120 SCI papers
Edited 7 monographs, participated in 22
2 first prizes of Hubei Province Science and Technology Progress Award
2 invention patents, 1 utility model patent, 1 software copyright

Work Experience

1986.7-1988.8 Physician, Hubei Medical University First Hospital
1991.7-1993.10 Physician in Cardiology, Hubei Medical University First Hospital
1993.10-1995.9 Attending Physician in Cardiology, Hubei Medical University First Hospital
1995.10-1999.3 Associate Chief Physician and Associate Professor in Cardiology, Hubei Medical University First Hospital
1999.3-2000.8 Chief Physician and Associate Professor in Cardiology, Hubei Medical University First Hospital
2000.8-2001.1 Chief Physician and Associate Professor in Cardiology, Renmin Hospital of Wuhan University
2001.1-present Chief Physician and Professor in Cardiology, Renmin Hospital of Wuhan University
1997.8-2000.8 Standing Committee Member and Vice President, Hubei Medical University First Hospital
2000.8-2005.4 Standing Committee Member and Vice President, Renmin Hospital of Wuhan University
2005.4-2014.6 Party Secretary and Vice President, Renmin Hospital of Wuhan University
2014.6-2016.9 President and Party Secretary, Renmin Hospital of Wuhan University
2016.9-2019.11 President, Renmin Hospital of Wuhan University
2019.1-present Standing Committee Member, Vice President and Medicine Minister, Wuhan University

Awards

2013: First Prize of Hubei Province Science and Technology Progress Award (Myocardial remodeling and clinical prevention)
2019: First Prize of Hubei Province Science and Technology Progress Award (Structural remodeling and prevention of heart failure)
2001: Second Prize of National Science and Technology Progress Award (Atrioventricular reentrant tachycardia and radiofrequency ablation)
2011: Second Prize of National Science and Technology Progress Award (Structural and neural remodeling in arrhythmias and clinical prevention)
2005: Second Prize of National Science and Technology Progress Award (Basic and clinical research on atrial fibrillation)
2016: First Prize of Hubei Province Science and Technology Progress Award (Construction and application of cardiovascular disease model animals)

Areas of Focus	Myocardial remodeling and cardiovascular disease prevention Mechanism and prevention of heart failure and cardiomyopathy
Publications	Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice, Zhang X, Hu C, Ma ZG, Hu M, Yuan XP, Yuan YP, Wang SS, Kong CY, Teng T, Tang QZ, 2023 Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications, Xie S, Xu SC, Deng W, Tang Q, 2023 Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination, Xie S, Xing Y, Shi W, Zhang M, Chen M, Fang W, Liu S, Zhang T, Zeng X, Chen S, Wang S, Deng W, Tang Q, 2022 Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases, Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q, 2022 Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling, Xie S, Chen M, Fang W, Liu S, Wu Q, Liu C, Xing Y, Shi W, Xu M, Zhang M, Chen S, Zeng X, Wang S, Deng W, Tang Q, 2022 PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy, Hu T, Wu Q, Yao Q, Yu J, Jiang K, Wan Y, Tang Q, 2023 Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice, Hu C, Zhang X, Hu M, Teng T, Yuan YP, Song P, Kong CY, Xu SC, Ma ZG, Tang QZ, 2022 BMI1 in the heart: Novel functions beyond tumorigenesis, Yang D, Liu HQ, Yang Z, Fan D, Tang QZ, 2021

Areas of Focus

Myocardial remodeling and cardiovascular disease prevention
Mechanism and prevention of heart failure and cardiomyopathy

Publications

Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice, Zhang X, Hu C, Ma ZG, Hu M, Yuan XP, Yuan YP, Wang SS, Kong CY, Teng T, Tang QZ, 2023
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications, Xie S, Xu SC, Deng W, Tang Q, 2023
Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination, Xie S, Xing Y, Shi W, Zhang M, Chen M, Fang W, Liu S, Zhang T, Zeng X, Chen S, Wang S, Deng W, Tang Q, 2022
Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases, Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q, 2022
Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling, Xie S, Chen M, Fang W, Liu S, Wu Q, Liu C, Xing Y, Shi W, Xu M, Zhang M, Chen S, Zeng X, Wang S, Deng W, Tang Q, 2022
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy, Hu T, Wu Q, Yao Q, Yu J, Jiang K, Wan Y, Tang Q, 2023
Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice, Hu C, Zhang X, Hu M, Teng T, Yuan YP, Song P, Kong CY, Xu SC, Ma ZG, Tang QZ, 2022
BMI1 in the heart: Novel functions beyond tumorigenesis, Yang D, Liu HQ, Yang Z, Fan D, Tang QZ, 2021

Myocardial Remodeling Cardiovascular Disease Prevention Heart Failure Cardiomyopathy Mechanism Clinical Treatment Research Pathophysiology Therapeutics

Wang Hairong - Wuhan University

Di Fan - Wuhan University

Hong Lei - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us